Loading
A phase 2 trial of iparomlimab and tuvonralimab in triple-negative breast cancer, run by Fudan University, not yet recruiting.
QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC. is a phase 2, randomised interventional study registered as NCT07509515 by Fudan University, with a registry enrolment figure of 60 participants, started 2026-04-15 and due to reach its primary completion in 2027-09-30. Interventions recorded: QLC5513; QLC5513+QL1706. Conditions listed: Triple-negative Breast Cancer (TNBC). Triple-negative eligibility wording from the registry: "TNBC invasive breast cancer confirmed by histology (specific definition: ER \<1% positive tumor cells by immunohistochemistry are defined as ER negative, PR \<1% positive tumor cells are defined as PR negative, HER2 0-1+ or HER2 ++ but negative by FISH without amplification was defined as HER2 negat". No results are recorded here; the registry entry is the source.
Shares Iparomlimab and tuvonralimab, Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Iparomlimab and tuvonralimab, Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.